Dr. Erwei Zeng holds a Doctorate in Epidemiology from Karolinska Institutet, where her master’s and doctoral research focused on population-based oncology. She has extensive expertise in real world evidence, with particular focus on treatment analysis, including comparative effectiveness, determinants of treatment, and safety. Dr. Zeng is highly experienced in leveraging national health registers to evaluate disease burden, survival outcomes, and long-term patient trajectories, providing valuable insights to support pharmaceutical research and healthcare decision-making.
